APA (7th ed.) Citation

Dijk, E. v., Biesma, H. D., Cordes, M., Smeets, D., Neerincx, M., Das, S., . . . Ylstra, B. (2018). Loss of chromosome 18q11.2-q12.1 is predictive for survival in patients with metastatic colorectal cancer treated with bevacizumab. Journal of clinical oncology, 36(20), . https://doi.org/10.1200/JCO.2017.77.1782

Chicago Style (17th ed.) Citation

Dijk, Erik van, et al. "Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab." Journal of Clinical Oncology 36, no. 20 (2018). https://doi.org/10.1200/JCO.2017.77.1782.

MLA (9th ed.) Citation

Dijk, Erik van, et al. "Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab." Journal of Clinical Oncology, vol. 36, no. 20, 2018, https://doi.org/10.1200/JCO.2017.77.1782.